Tengrinews TV Радио Tengri FM Радио Жұлдыз FM Laws of Kazakhstan
Write us +7 (727) 388 8020 +7 (717) 254 2710
искать через Tengrinews.kz
искать через Google
искать через Yandex
USD / KZT - 319.65
EUR / KZT - 393.33
CNY / KZT - 50.47
RUB / KZT - 5.67

US to cut funding on Turkish Chinese-missile purchase

14 декабря 2013, 13:20
©Reuters/Larry Downing
©Reuters/Larry Downing
The US Congress is set to adopt a law next week forbidding Turkey from using American funds to acquire a $4 billion missile system from a Chinese company blacklisted by Washington, AFP reports.

The United States has voiced deep concern over Turkey's decision in September to enter negotiations with China Precision Machinery Export-Import Corporation for its first long-range anti-missile system.

CPMIEC, which makes the HQ-9 missile system, is under US sanctions for selling arms and missile technology to Iran and Syria.

Turkey's move also irritated its allies in NATO, which has said missile systems within the transatlantic military alliance must be compatible with each other.

The annual US defense authorization bill, passed Thursday by the House, contains a clause barring the use of "2014 funds to integrate missile defense systems of the People's Republic of China into US missile defense systems."

"Such a system would not be compatible with, and should not be integrated with, missile defense systems of the North Atlantic Treaty Organization," the Senate and House Armed Services Committees said.

Without US subsidies, the cost for Turkey to install the Chinese missiles becomes steeper.

The bill is expected to be approved in the Senate next week, before being signed into law by President Barack Obama.

CPMIEC beat competition from a US partnership of Raytheon and Lockheed Martin, Russia's Rosoboronexport, and Italian-French consortium Eurosam for the multibillion-dollar deal.

These companies have until January 31 to submit new bids.

Turkey will make its final decision by mid-2014.

Хотите больше статей? Смотреть все
Добавить комментарий
Most Read
Most Discussed